Press release
Liver Disease Therapeutics Market Projected to Reach USD 34.78 Billion by 2030, With a CAGR of 7.4% from 2024
Liver Disease Therapeutics Market Research Report
Liver Disease Therapeutics Market Report Overview:
In a groundbreaking revelation, the global Liver Disease Therapeutics Market is poised for unprecedented growth, with projections indicating a staggering surge in revenue. Latest reports reveal that the market, valued at USD 21.10 Billion in 2023, is expected to skyrocket at a Compound Annual Growth Rate (CAGR) of 7.4% from 2024 to 2030. If these forecasts hold true, the market is on track to reach a monumental USD 34.78 Billion by the end of the decade.
Liver diseases, encompassing a range of ailments affecting millions worldwide, have long posed significant health challenges. Annually, over 2 million lives are claimed by liver-related illnesses, making up 4% of global mortality. Amidst this concerning backdrop, the Liver Disease Therapeutics Market emerges as a beacon of hope, offering innovative treatments and solutions to combat these afflictions.
To explore a sample of the report, please follow this link: https://www.maximizemarketresearch.com/request-sample/229296
Liver Disease Therapeutics Market Scope and Research Methodology:
Our research methodology blends primary and secondary research techniques to gather and analyze data from diverse and reliable sources. Employing various analytical tools and models, the report delivers accurate market forecasts and insights. Additionally, it includes a thorough SWOT analysis and Porter's Five Forces analysis to evaluate the competitive landscape and market attractiveness.
Liver Disease Therapeutics Market Segmentation:
The report offers a detailed segmentation of the Liver Disease Therapeutics market based on various parameters such as:
by Treatment Type
Antiviral Drugs
Immunosuppressant
Vaccines
Immunoglobulin
Corticosteroids
Targeted Therapy
Chemotherapy
by Disease Type
Hepatitis
Autoimmune Diseases
Non-alcoholic Fatty Liver Disease (NAFLD)
Cancer
Genetic Disorders
Regarding Treatment Type, the Global Liver Disease Therapeutics Market is dominated by the Antiviral segment, which accounts for around 43% of the market. The category is anticipated to increase at a compound annual growth rate (CAGR) of 7.4% over the projected period, based on MMR study. Within the Global Liver Disease Therapeutics Market, it is notable for being the leading segment. The market for liver disease therapies is driven by the rise in the prevalence of viral hepatitis (B & C) and the population's increased alcohol intake. Prominent industry participants, including Gilead Sciences, Abbvie, Merck & Co., and Chimeric, have been actively involved in the invention, investigation, and advancement of several antiviral medications. Antiviral medications are used to treat chronic hepatitis B, which can cause hepatocellular carcinoma and liver cirrhosis.
To obtain a complimentary report sample, click here: https://www.maximizemarketresearch.com/request-sample/229296
Liver Disease Therapeutics Market Key Players:
The report profiles key players in the Liver Disease Therapeutics market, providing insights into their strategies, product portfolios, and recent developments.
1. Johnson & Johnson Services Inc.
2. F. Hoffmann-La Roche Ltd.
3. Pfizer Inc.
4. Abbott Laboratories
5. Novartis AG
6. Eli Lilly and Company
7. Gilead Sciences
8. Bristol Myers Squibb
9. AbbVie Inc.
10. Zydus Pharmaceuticals Inc.
11. Intercept Pharmaceuticals, Inc.
12. Merck & Co., Inc.
13. Bristol-Myers Squibb Company
14. Johnson & Johnson
15. Takeda Pharmaceutical Company Limited
16. Eli Lilly and Company
17. Astellas Pharma Inc., Bristol-Myers Squibb
18. GlaxoSmithKline Plc,
19. Merck & Co. Inc.
20. Sanofi S.A
Liver Disease Therapeutics Market Regional Insights:
It offers insights into the regional dynamics of the Liver Disease Therapeutics market, highlighting trends, growth drivers, and challenges across different geographic regions. The report provides a comprehensive analysis of market dynamics, regulatory frameworks, and investment opportunities in major markets such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Key Inquiries:
• What are the key factors driving the growth of the Liver Disease Therapeutics market?
• What are the major challenges hindering market growth, and how can they be addressed?
• What are the emerging trends and opportunities in the market?
• Who are the leading players in the Liver Disease Therapeutics market, and what are their strategies to maintain their position?
• Which regions are expected to witness significant growth in the forecast period, and why?
For further details, please refer to the link provided: https://www.maximizemarketresearch.com/request-sample/229296
Primary Offerings:
• Comprehensive analysis of the Liver Disease Therapeutics market, including drivers, restraints, opportunities, and challenges.
• In-depth segmentation of the market based on product type, application, end-user industry, and geography.
• Profiling of key players and assessment of their strategies, product portfolios, and recent developments.
• Regional analysis with insights into market dynamics, regulatory landscape, and investment opportunities.
• Market forecasts and trends for the period 2023-2029, aiding stakeholders in making informed decisions.
For additional reports on related topics, please visit our website:
Dimmer and Color Tunable Market https://www.maximizemarketresearch.com/market-report/dimmer-and-color-tunable-market/195193/
Middle East and Africa Frozen Food Market https://www.maximizemarketresearch.com/market-report/middle-east-and-africa-frozen-food-market/195245/
AI Sensor Market https://www.maximizemarketresearch.com/market-report/ai-sensor-market/195358/
Bathroom Sink Market https://www.maximizemarketresearch.com/market-report/bathroom-sink-market/195423/
Power Grid Market https://www.maximizemarketresearch.com/market-report/power-grid-market/195591/
Organic Yogurt Market https://www.maximizemarketresearch.com/market-report/organic-yogurt-market/196190/
Bohrium Market https://www.maximizemarketresearch.com/market-report/bohrium-market/198422/
Wedding Wear Market https://www.maximizemarketresearch.com/market-report/wedding-wear-market/199621/
North America Lithium Metal Market https://www.maximizemarketresearch.com/market-report/north-america-lithium-metal-market/199801/
South America Military Land Vehicles Market https://www.maximizemarketresearch.com/market-report/south-america-military-land-vehicles-market/199932/
Contact Us:
Maximize Market Research Pvt. Ltd.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
Phone: +91 9607365656
Email: sales@maximizemarketresearch.com
Website: www.maximizemarketresearch.com
About Us:
Maximize Market Research is a prominent market research and business consulting firm serving clients globally. We specialize in delivering tailored research solutions that address the specific needs and objectives of our clients across various industries. With a team of seasoned analysts and consultants, we aim to provide actionable insights and strategic recommendations to assist businesses in navigating market uncertainties and achieving sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Disease Therapeutics Market Projected to Reach USD 34.78 Billion by 2030, With a CAGR of 7.4% from 2024 here
News-ID: 3411767 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a …
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million.
Bangladesh Ceramics Tiles Market Overview:
The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.…
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030.
Furfural Market Overview:
The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,…
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to …
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion.
Chemical Protective Clothing Market Overview:
The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range of…
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR …
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion.
Prefabricated Homes Market Overview:
The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizes…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
